Hyperfine (HYPR) Shareholder's Equity (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | 34.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.36 Mn |
| Dec 31, 2025 | 41.01 Mn |
| Sep 30, 2025 | 26.87 Mn |
| Jun 30, 2025 | 35.13 Mn |
| Mar 31, 2025 | 43.11 Mn |
| Dec 31, 2024 | 49.04 Mn |
| Sep 30, 2024 | 58.32 Mn |
| Jun 30, 2024 | 66.76 Mn |
| Mar 31, 2024 | 75.64 Mn |
| Dec 31, 2023 | 84.40 Mn |
| Sep 30, 2023 | 93.77 Mn |
| Jun 30, 2023 | 103.29 Mn |
| Mar 31, 2023 | 112.74 Mn |
| Dec 31, 2022 | 123.72 Mn |
| Sep 30, 2022 | 134.98 Mn |
| Jun 30, 2022 | 150.51 Mn |
| Mar 31, 2022 | 166.56 Mn |
| Dec 31, 2021 | 186.23 Mn |
| Sep 30, 2021 | -101.06 Mn |
| Jun 30, 2021 | -87.31 Mn |
| Mar 31, 2021 | -67.83 Mn |
| Dec 31, 2020 | -61.05 Mn |